Affiliation:
1. Department of Pharmaceutical Sciences University at Buffalo, The State University of New York Buffalo New York USA
2. Department of Neurology University at Buffalo, The State University of New York Buffalo New York USA
Abstract
AbstractObjectiveTo model interdependencies of serum neurofilament light chain (sNfL), a clinically useful biomarker of axonal injury in neurological diseases, with demographic, anthropometric, physiological, and disease biomarkers in the United States population.MethodssNfL and 80 biomarkers were obtained from the National Health and Nutrition Examination Survey (n = 2071, age: 20–75 years). Body habitus and composition, electrolytes, blood cell, metabolic, liver, and kidney function biomarkers, and common diseases were assessed with weighted regression adjusted for age, sex, and race/ethnicity. Salient biomarkers were modeled with ensemble learning; a Bayesian network structure was obtained for interdependencies.ResultsAge was strongly associated with sNfL. sNfL levels were 13% higher in men versus women. Mexican Americans had 18.5% lower sNfL versus Non‐Hispanic Whites. sNfL was similar in pregnant versus nonpregnant women. Lymphocyte, and neutrophil numbers, and phosphorus, and chloride levels were associated with sNfL. Multiple liver function (e.g., albumin and gamma‐glutamyltransferase), renal function (e.g., creatinine and urea), and carbohydrate/lipid metabolism markers (e.g., glucose and triglycerides) were associated with sNfL. A 50% greater creatinine was associated with 26.8% greater sNfL. Diabetes, kidney disease, congestive heart failure, and stroke were associated with sNfL. The ensemble learning algorithm predicted high sNfL outliers with 5.06%–9.16% test error. Bayesian network modeling indicated sNfL had neighbor dependencies with age, creatinine, albumin, and chloride.InterpretationsNfL is associated with age, kidney and liver function, diabetes, blood cell subsets, and electrolytes. sNfL may be a useful biomarker for biological age of the whole body and major organ systems including the brain.
Reference28 articles.
1. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
2. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
3. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome;Disanto G;J Neurol Neurosurg Psychiatry,2016
4. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
5. Siemens Healthineers.Siemens Healthineers receives FDA breakthrough device designation for sNfL test in multiple sclerosis.2022Accessed December 28 2023.